Filing Details

Accession Number:
0001140361-12-030809
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-21 16:07:09
Reporting Period:
2012-06-19
Filing Date:
2012-06-21
Accepted Time:
2012-06-21 16:07:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1319606 Andrew Miller C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Evp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-19 12,500 $21.00 18,922 No 4 M Direct
Common Stock Acquisiton 2012-06-19 2,500 $8.43 21,422 No 4 M Direct
Common Stock Acquisiton 2012-06-19 2,437 $20.47 23,859 No 4 M Direct
Common Stock Disposition 2012-06-19 12,500 $41.43 11,359 No 4 S Direct
Common Stock Disposition 2012-06-19 4,937 $41.77 6,422 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-06-19 12,500 $0.00 12,500 $21.00
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-06-19 2,500 $0.00 2,500 $8.43
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-06-19 2,437 $0.00 2,437 $20.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-04-14 No 4 M Direct
10,000 2016-04-28 No 4 M Direct
19,501 2017-04-29 No 4 M Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 3, 2012.
  2. 25% of the shares subject to the grant vested and became exercisable on April 14, 2009; thereafter, 2.0833% of the shares subject to the grant vested or will vest and become exercisable on each monthly anniversay of the First Vesting Date until 100% vested.
  3. 25% of the shares subject to the grant vested and became exercisable on April 28, 2010; thereafter, 2.0833% of the shares vested or will vest and become exercisable on each monthly anniversary of the First Vesting Date until 100% vested.
  4. 25% of the shares subject to the grant vested and became exercisable on April 29, 2011; thereafter, 2.0833% of the shares subject to the grant vested or will vest and become exercisable on each monthly anniversay of the First Vesting Date until 100% vested.